Patience under uncertainty: also hoping for CVR distribution Acrotech focussed on commercialization of oncology products in US market, including Marqibo https://acrotechbiopharma.com/our-products/ It is unlikely they can advise us on the commercialization progress in any detail. CASI betting on Chinese market for oncology products, including Marqibo. Still awaiting approval in this market. https://www.fool.com/earnings/call-transcripts/2020/03/17/casi-pharmaceuticals-inc-casi-q4-2019-earnings-cal.aspx